Atea Pharmaceuticals Inc (AVIR) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year? [Yahoo! Finance]